150,200 Shares of Merit Medical Systems, Inc. $MMSI Purchased by First Eagle Investment Management LLC

First Eagle Investment Management LLC bought a new position in Merit Medical Systems, Inc. (NASDAQ:MMSI – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 150,200 shares of the medical instruments supplier’s stock, valued at approximately $12,952,000. First Eagle Investment Management LLC owned approximately 0.25% of Merit Medical Systems as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently made changes to their positions in MMSI. William Blair Investment Management LLC bought a new position in Merit Medical Systems in the 2nd quarter valued at approximately $78,894,000. Irenic Capital Management LP purchased a new stake in Merit Medical Systems during the 2nd quarter valued at $37,623,000. The Manufacturers Life Insurance Company purchased a new stake in Merit Medical Systems during the 2nd quarter valued at $33,591,000. Bank of New York Mellon Corp bought a new stake in shares of Merit Medical Systems in the 2nd quarter worth $28,470,000. Finally, J. Goldman & Co LP bought a new stake in shares of Merit Medical Systems in the 2nd quarter worth $16,835,000. Institutional investors own 99.66% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on MMSI. JPMorgan Chase & Co. boosted their price target on Merit Medical Systems from $95.00 to $110.00 and gave the stock an “overweight” rating in a research note on Friday, October 30th. Wells Fargo & Company upped their price target on Merit Medical Systems from $83.00 to $92.00 and gave the company an “equal weight” rating in a report on Friday, October 30th. Weiss Ratings raised Merit Medical Systems from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, October 12th. Robert W. Baird set a $98.00 price objective on Merit Medical Systems in a report on Friday, July 31st. Finally, BTIG Research lifted their price objective on Merit Medical Systems from $105.00 to $110.00 and gave the stock a “buy” rating in a report on Friday, October 30th. Eight analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $105.91.

Get Our Latest Research Report on Merit Medical Systems

Merit Medical Systems Stock Up 1.7%

Shares of Merit Medical Systems stock opened at $85.93 on Thursday. The company has a market cap of $5.15 billion, a price-to-earnings ratio of 21.72, a price-to-earnings-growth ratio of 2.06 and a beta of 0.56. The company’s 50 day moving average is $87.87 and its 200 day moving average is $77.48. Merit Medical Systems, Inc. has a twelve month low of $59.74 and a twelve month high of $94.85. The company has a quick ratio of 3.05, a current ratio of 4.52 and a debt-to-equity ratio of 0.42.

Merit Medical Systems (NASDAQ:MMSI – Get Free Report) last posted its earnings results on Thursday, October 29th. The medical instruments supplier reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.08. The business had revenue of $416.24 million during the quarter, compared to the consensus estimate of $410.56 million. Merit Medical Systems had a net margin of 9.94% and a return on equity of 14.12%. The firm’s revenue was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.92 EPS. Research analysts anticipate that Merit Medical Systems, Inc. will post 3.86 EPS for the current year.

Insider Activity

In other news, insider Brian Lloyd sold 16,722 shares of the firm’s stock in a transaction on Monday, November 16th. The stock was sold at an average price of $86.33, for a total value of $1,443,610.26. Following the transaction, the insider directly owned 60,132 shares in the company, valued at $5,191,195.56. This trade represents a 21.76% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.70% of the stock is currently owned by company insiders.

Merit Medical Systems Profile

(Free Report)

Merit Medical Systems develops, manufactures and markets medical devices used in diagnostic and interventional procedures. Its products support clinicians in areas including cardiology, radiology, oncology and endoscopy. The company’s portfolio includes devices and accessories for vascular access, diagnostic and therapeutic procedures, drainage, biopsy and embolization. Merit serves hospitals, clinics and other healthcare providers through direct sales and distribution channels. Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves customers in the United States and internationally.

See Also

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI – Free Report).

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.